ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $134,000 | +15.5% | 2,900 | -62.0% | 0.01% | +62.5% |
| Q3 2018 | $116,000 | -57.5% | 7,639 | -53.2% | 0.01% | -57.9% |
| Q2 2018 | $273,000 | +116.7% | 16,309 | +65.1% | 0.02% | +58.3% |
| Q4 2017 | $126,000 | -43.5% | 9,879 | -45.7% | 0.01% | -42.9% |
| Q3 2017 | $223,000 | +1293.8% | 18,205 | +803.5% | 0.02% | +950.0% |
| Q2 2017 | $16,000 | -87.6% | 2,015 | -86.1% | 0.00% | -85.7% |
| Q1 2017 | $129,000 | +12.2% | 14,523 | +10.9% | 0.01% | +7.7% |
| Q4 2016 | $115,000 | +945.5% | 13,100 | +415.7% | 0.01% | +550.0% |
| Q3 2015 | $11,000 | – | 2,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |